Heartworm disease — caused by a parasite transmitted by mosquitoes — causes severe cardiovascular damage in dogs. Prevention is safe and inexpensive; treatment of established disease is difficult, costly, and carries significant welfare risk.
Heartworm disease causes progressive cardiovascular suffering that is entirely preventable through inexpensive monthly prophylaxis. Dogs with established infection experience exercise intolerance, coughing, and eventually the severe discomfort of heart failure — a welfare trajectory that proper prevention would have avoided. The treatment protocol for established disease is itself a welfare challenge: the melarsomine injection series requires months of strict cage rest to prevent embolism from dying worms, a period of enforced confinement that distresses active dogs. Prevention is dramatically preferable to treatment — in terms of both animal welfare and owner cost. Access to preventive medication is a welfare equity issue in regions where heartworm is endemic but veterinary care is expensive or geographically inaccessible. Low-cost preventive care programmes that make monthly prophylaxis available to all dog owners regardless of income directly protect canine welfare at population scale.